Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial
阿司匹林或依夫马罗替诺酮α治疗重症COVID-19肺炎患者：一项随机、II期试验
期刊:Critical Care Medicine
影响因子:6
doi:10.1097/CCM.0000000000005716
Waters, Michael; McKinnell, James A; Kalil, Andre C; Martin, Greg S; Buchman, Timothy G; Theess, Wiebke; Yang, Xiaoying; Lekkerkerker, Annemarie N; Staton, Tracy; Rosenberger, Carrie M; Pappu, Rajita; Wang, Yehong; Zhang, Wenhui; Brooks, Logan; Cheung, Dorothy; Galanter, Joshua; Chen, Hubert; Mohan, Divya; Peck, Melicent C
